Source: International Congress 2019 – Treatment of lung cancer
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
A. Bazhenov (Ekaterinburg, Russian Federation), I. Motus (Ekaterinburg, Russian Federation), E. Altman (Nahariya, Israel), I. Medvinsky (Ekaterinburg, Russian Federation), M. Alexandrov (Ekaterinburg, Russian Federation). SURGERY OF IA STAGE LUNG CARCINOMA. SUBLOBAR RESECTIONS. TO WHOM AND WHEN?. 379

Member's Comments

No comment yet.

Related content which might interest you: THE HUMAN LUNG: DID EVOLUTION GET IT WRONG? Source: Eur Respir J 2007; 29: 823 Year: 2007 CHARACTERISTICS OF SECOND TUMORS AND RECURRENCES IN SURGICALLY TREATED LUNG CANCER Source: International Congress 2019 – Early detection, follow-up and epidemiology of lung cancer Year: 2019 EXPERIENCE WITH RADIOFREQUENCY ABLATION OF LUNG TUMORS Source: Virtual Congress 2021 – Therapy of lung cancer Year: 2021 INTERSTITIAL LUNG DISEASE IN A LUNG CANCER SCREENING PROGRAM: PREVALENCE AND ASSOCIATION WITH CANCER. Source: International Congress 2018 – Clinical news in idiopathic interstitial pneumonias Year: 2018 EARLY DIAGNOSIS OF LUNG VENTILATION EVENNESS DISORDERS USING NONINVASIVE IMAGING Source: Virtual Congress 2021 – Pulmonary neoplasia and related pathologies Year: 2021 PROGNOSIS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) ACCORDING TO STRENGTH IN UPPER LIMBS Source: International Congress 2019 – Lung function evaluation and prognosis of airway diseases Year: 2019 LUNG ADENOCARCINOMA: CLINICAL CHARACTERISTICS, MOLECULAR STUDY, DIAGNOSIS AND TREATMENT. Source: Virtual Congress 2021 – Screening, diagnosis, management and prognosis of lung cancer Year: 2021 PULMONARY REHABILITATION AFTER LUNG TRANSPLANTATION: DEVELOPMENT OF A PROTOCOL Source: International Congress 2019 – Lung transplantation: from bench to bedside Year: 2019 MULTIDISCIPLINARY APPROACH IN THE EVALUATION AND MANAGEMENT OF PATIENTS WITH MALIGNANT PLEURAL MESOTHELIOMA. A SINGLE CENTER EXPERIENCE. Source: Virtual Congress 2020 – Novel directions in pleural disease: bench to bedside Year: 2020 DYNAMICS OF GLUTATION SYSTEM INDICATORS IN CHRONIC LUNG DISEASES ON MODEL INHALED TREATMENT Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies Year: 2020 TRANSCRIPTOMIC PROFILING REVEALS M1-HIGH TUMOUR ASSOCIATED MACROPHAGES THAT ORCHESTRATE THE ADAPTIVE ANTI-TUMOUR RESPONSE IN HUMAN LUNG CANCER Source: International Congress 2017 – Gene signatures in bronchial diseases Year: 2017 MANAGEMENT OF PULMONARY METASTASIS OF COLO-RECTAL CANCERS Source: Virtual Congress 2021 – Oncology, the mediastinum and infectious lung disease Year: 2021 ASSOCIATION OF EXERCISE CAPACITY AND ENDOTHELIAL FUNCTION IN PATIENTS WITH FIBROSING INTERSTITIAL LUNG DISEASE Source: Virtual Congress 2021 – Peripheral muscle function, exercise capacity and functional status in respiratory disease Year: 2021 EVOLUTION OF CRAVING ACCORDING TO THE TREATMENT USED TO STOP SMOKING. Source: Virtual Congress 2020 – From tobacco control policy to smoking cessation Year: 2020 ANGIOTENSIN II BLOCKERS IN OBSTRUCTIVE PULMONARY DISEASE: A RANDOMISED CONTROLLED TRIAL. Source: Eur Respir J 2006; 28: 1292 Year: 2006 NOVEL KLF4-FOXO1 INTERACTOME IN LUNG FIBROBLASTS:REGULATOR OF MYOFIBROBLASTS IN HYPEROXIA-INDUCED LUNG INJURY Source: Virtual Congress 2020 – Airway development in health and disease Year: 2020 PERINATAL INFLAMMATION AND INTRAUTERINE GROWTH RETARDATION ARE BOTH ASSOCIATED WITH LUNG FUNCTION IMPAIRMENT AT 12 YEARS OF AGE IN VERY PRETERM INFANTS Source: International Congress 2018 – Assessing pathophysiology in children Year: 2018 ORAL MORPHINE IS SAFE IN SYMPTOMATIC PATIENTS WITH FIBROTIC INTERSTITIAL LUNG DISEASES Source: International Congress 2019 – Treatment and prognosis of idiopathic interstitial pneumonia Year: 2019 MONITORING IMMUNODYNAMICS IN IMMUNE CHECKPOINT INHIBITOR THERAPY FOR STAGE IIIB/IV NON-SMALL CELL LUNG CANCER Source: International Congress 2018 – Lung cancer: personalised medicine Year: 2018 IMPROVING HOME OXIGEN THERAPY IN PATIENTS WITH INTERSTITIAL LUNG DISEASES (ILDs): APPLICATION OF A PORTABLE NON-INVASIVE VENTILATION (NIV) DEVICE Source: International Congress 2019 – The world of idiopathic pulmonary fibrosis Year: 2019